FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Expires: February 28, 2011
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Abovitz Rony A 		2. Issuer Name and Ticker or Trading Symbol

MAKO Surgical Corp. [ MAKO ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
SVP, Chief Visionary Officer
(Last)          (First)          (Middle)

C/O MAKO SURGICAL CORP., 2555 DAVIE ROAD 		3. Date of Earliest Transaction (MM/DD/YYYY)

12/23/2009
(Street)

FT. LAUDERDALE, FL 33317
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   12/23/2009     M    2867   A $0.6666   2867   D    
Common Stock   12/23/2009     M    6999   A $1.2726   9866   D    
Common Stock   12/23/2009     S    9866   D $10.8922   (1) 0   D    
Common Stock   12/24/2009     M    3600   A $1.2726   3600   D    
Common Stock   12/24/2009     S    3600   D $10.8668   (2) 0   D    
Common Stock   12/28/2009     M    22300   A $1.2726   22300   D    
Common Stock   12/28/2009     S    22300   D $11.1992   (3) 0   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy)   $0.6666   12/23/2009     M         2867    12/16/2004   12/16/2014   Common Stock   2867   $0.00   0   D    
Employee Stock Option (Right to Buy)   $1.2726   12/23/2009     M         6999      (4) 7/18/2015   Common Stock   6999   $0.00   75509   D    
Employee Stock Option (Right to Buy)   $1.2726   12/24/2009     M         3600      (4) 7/18/2015   Common Stock   3600   $0.00   71909   D    
Employee Stock Option (Right to Buy)   $1.2726   12/28/2009     M         22300      (4) 7/18/2015   Common Stock   22300   $0.00   49609   D    

Explanation of Responses:
( 1)  The price in Column 4 is a weighted average price per share. The shares were sold in multiple transasctions at prices ranging from $10.68 per share to $11.04 per share. The reporting person will provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
( 2)  The price in Column 4 is a weighted average price per share. The shares were sold in multiple transasctions at prices ranging from $10.76 per share to $10.98 per share. The reporting person will provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
( 3)  The price in Column 4 is a weighted average price per share. The shares were sold in multiple transasctions at prices ranging from $10.89 per share to $11.38 per share. The reporting person will provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
( 4)  The option became exercisable over four years as follows: twenty-five percent (25%) on July 18, 2006, the first anniversary of the date on which the option was granted, and the remaining seventy-five percent (75%) ratably over the thirty-six (36) months thereafter.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Abovitz Rony A
C/O MAKO SURGICAL CORP.
2555 DAVIE ROAD
FT. LAUDERDALE, FL 33317

SVP, Chief Visionary Officer

Signatures
/s/ Menashe R. Frank, attorney in fact 12/28/2009
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Mako Surgical Corp. (MM) (NASDAQ:MAKO)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024 Mako Surgical Corp. (MM) 차트를 더 보려면 여기를 클릭.
Mako Surgical Corp. (MM) (NASDAQ:MAKO)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024 Mako Surgical Corp. (MM) 차트를 더 보려면 여기를 클릭.